This test screens for 50 cancers — but whether Medicare and other health insurers will cover it hinges on FDA approval

According to a report by MarketWatch… Grail’s Galleri test looks for 50 cancers from a blood draw, but a major study failed to prove it could detect later-stage cancers. complete report is on link below: Source: https://www.marketwatch.com/story/fda-advisers-are-reviewing-a-multicancer-detection-test-medicare-coverage-could-follow-77cb8817?mod=mw_rss_topstories